Group One Trading’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$54.3K Buy
2,200
+1,800
+450% +$31.5K ﹤0.01% 5200
2025
Q4
$6.76K Hold
400
﹤0.01% 7038
2025
Q3
$8.69K Buy
400
+300
+300% +$4.98K ﹤0.01% 7255
2025
Q2
$1.43K Buy
+100
New +$1.58K ﹤0.01% 7492
2025
Q1
Sell
-1,000
Closed -$13.3K 7800
2024
Q4
$13.3K Hold
1,000
﹤0.01% 5945
2024
Q3
$6K Buy
1,000
+900
+900% +$3.8K ﹤0.01% 5809
2024
Q2
$329 Hold
100
﹤0.01% 6491
2024
Q1
$375 Buy
+100
New +$437 ﹤0.01% 6768
2022
Q2
Sell
-7,000
Closed -$31K 7992
2022
Q1
$31K Hold
7,000
﹤0.01% 6452
2021
Q4
$30K Buy
7,000
+2,900
+71% +$13.9K ﹤0.01% 6721
2021
Q3
$21K Buy
+4,100
New +$21.3K ﹤0.01% 7138

Other funds holding ETON

Group One Trading's ETON Position: Q1 2026 in Review

Group One Trading sold out of Eton Pharmaceutcials (ETON) in Q1 2026, closing a stake of 500 shares — an estimated $8.74K sold.

Group One Trading first reported a position in ETON in Q3 2021 and held it in 9 quarters. The position peaked at $166K in Q4 2021. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Group One Trading reported no remaining Eton Pharmaceutcials position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 500 Eton Pharmaceutcials shares in Q1 2026, an estimated $8.74K.
  • Group One Trading first reported a position in Eton Pharmaceutcials in Q3 2021 and held it in 9 quarters.
  • Group One Trading's Eton Pharmaceutcials position peaked at $166K in Q4 2021.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.